You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 85 No. 2, FEBRUARY 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CHEMICAL STRUCTURE OF SUBSTANCES EFFECTIVE IN TREATMENT OF PARKINSONISM

DONALD S. GAIR; JAMES DUCEY

Arch Intern Med. 1950;85(2):284-298.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN 1882 GNAUCK1 discovered the effectiveness of hyoscine in palliation of the symptoms of parkinsonism and opened the present era of medical therapy in that disease. In the next half century or more little was added besides the demonstration of similar action by the other alkaloids in the solanaceous group, atropine and hyoscyamine; extracts of the stramonium leaf,2 and preparations of other plants containing the mydriatic alkaloids.3 No one drug or combination of drugs has established its supremacy over the others because of the notoriously variable manifestations of the disease and pattern of response to therapy, which is constant only in the definite residue of obvious symptomatology following optimal medication.4 In addition to certain drugs with limited application, such as amphetamine sulfate, occasionally useful in the postencephalitic syndrome, a wide assortment of compounds with nonspecific effect have been reported on, including barbiturates, salicylates,5 and vitamins. . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Department of Neurology of the Harvard Medical School; the Neurological Unit of the Boston City Hospital, and the Tewksbury State Hospital and Infirmary.


Footnotes

A preliminary report of this paper was read at the meeting of the Boston Chapter of the American Federation for Clinical Research, Boston, April 19, 1949.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.